Related Experiment Video
Updated: May 6, 2026

09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
9.8K
Gastrointestinal involvement in systemic mastocytosis
Gut
|February 1, 1976
Summary
Systemic mastocytosis patients with gastrointestinal issues showed normal blood histamine but high gastric tissue histamine. Urticaria-like lesions and elevated tissue histamine, not high blood histamine, likely cause GI symptoms.
Area of Science:
- Gastroenterology
- Hematology
- Oncology
Background:
- Systemic mastocytosis (SM) is a rare disorder characterized by abnormal mast cell proliferation.
- Gastrointestinal (GI) manifestations are common in SM, but their underlying mechanisms are not fully understood.
- Previous studies have focused on serum histamine levels, with inconsistent findings.
Purpose of the Study:
- To investigate the relationship between gastrointestinal symptoms, mast cell infiltration, and histamine levels in patients with systemic mastocytosis.
- To determine whether elevated serum histamine or tissue histamine content is more closely associated with GI pathology in SM.
Main Methods:
- Studied four consecutive patients diagnosed with systemic mastocytosis.
- Performed endoscopy of the stomach and colon, including mucosal biopsies.
- Assessed serum gastrin and histamine levels.
- Measured histamine content in gastric tissue samples.
Main Results:
- All patients exhibited urticaria-like papulae on endoscopy, either spontaneously or after provocation.
- No significant increase in mast cells was observed in mucosal biopsies.
- Serum gastrin and histamine levels were consistently normal across all patients.
- A markedly increased histamine content was found in gastric tissue from three of the four patients.
Conclusions:
- Gastrointestinal symptoms in systemic mastocytosis may be linked to elevated histamine levels within gastric tissue, rather than hyperhistaminemia.
- Urticaria-like lesions observed during endoscopy are a potential indicator of increased tissue histamine.
- Further research is needed to elucidate the precise role of tissue-bound histamine in SM-associated GI dysfunction.
More Related Videos
Related Concept Videos
Gastrointestinal Motility Disorders
1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Gastritis-II: Pathophysiology
1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Gastritis II: Pathophysiology
87
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
87
Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Inflammatory Bowel Disease IV: Clinical Manifestations
64
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64

